ACTA PARASITOLOGICA, published by SPRINGER INT PUBL AG, stands as a pivotal journal within the field of Parasitology, boasting an ISSN of 1230-2821 and an E-ISSN of 1896-1851. Based in Germany, it has been providing valuable insights and research contributions since its inception, with publishing years converging from 1992 to 1994 and consistently from 1996 to 2024. The journal is recognized in the 2023 Category Quartiles as Q3 in Parasitology, indicating its significant impact and growing influence in the discipline, reflected in its Rank #43/79 in the Scopus Ranks for Immunology and Microbiology (Parasitology). Although not currently available in an Open Access format, ACTA PARASITOLOGICA remains a critical resource for researchers, professionals, and students alike, serving as a platform for the latest developments, methodologies, and discoveries in parasitic research. Its ongoing commitment to advancing the understanding of parasitic diseases and their impact on health and ecosystems underscores its importance in both academia and public health.

International Journal for Parasitology-Drugs and Drug Resistance, published by ELSEVIER SCI LTD, is a premier open access journal that has been at the forefront of parasitology research since its inception in 2011. With an impressive impact factor and recognition as a Q1 journal in multiple categories including Infectious Diseases, Parasitology, and Pharmacology, it serves as an essential resource for researchers, professionals, and students looking to advance their understanding of drug resistance and therapeutic strategies against parasitic infections. Based in the Netherlands, the journal’s scope encompasses a wide range of topics dedicated to innovative drug development, resistance mechanisms, and treatment efficacy, empowering the scientific community with high-quality, peer-reviewed articles. Engaging with this publication not only enhances the discourse on parasitological challenges but also contributes to the global fight against infectious diseases. With the adoption of open access since 2011, the journal ensures that valuable insights and knowledge remain readily accessible to all stakeholders in the field.

FOLIA PARASITOLOGICA is a distinguished scholarly journal published in the Czech Republic, focusing on the field of parasitology. With a commitment to advancing knowledge in parasitology, the journal covers a wide array of topics including the biology and control of parasites, host-parasite interactions, and epidemiology. Having been in circulation since 1971 and currently converging its years of research until 2024, FOLIA PARASITOLOGICA has established itself as a vital resource for researchers, professionals, and students in immunology and microbiology, currently ranked in the Q3 category for Parasitology. Although it does not operate under an open-access model, the journal's relevance is underscored by its Scopus ranking, where it is positioned 47th out of 79 in the field, reflecting the high standards of research it publishes. By hosting a range of studies and reviews, FOLIA PARASITOLOGICA continues to contribute significantly to the scientific community, fostering advancements that enhance our understanding and management of parasitic diseases.

MOLECULAR AND BIOCHEMICAL PARASITOLOGY is a renowned journal published by Elsevier, focusing on the crucial intersections of molecular biology and parasitology. Since its inception in 1980, this journal has aimed to advance our understanding of parasitic organisms at the biochemical and molecular levels, providing a dedicated platform for researchers studying host-parasite interactions, parasite genetics, and diagnostic methodologies. Although it currently holds a quartile status of Q4 in Molecular Biology and Q3 in Parasitology for the year 2023, it remains a vital resource within the academic community, boasting a variety of research articles, reviews, and case studies that explore innovative treatment strategies and the molecular biology of parasites. Researchers and students alike can benefit from the journal's contributions to the field, despite its traditional publishing model, as the content remains pivotal for ongoing studies and advancements in parasitology.

International Journal for Parasitology, published by Elsevier Sci Ltd, stands as a premier platform for disseminating groundbreaking research in the fields of parasitology and infectious diseases. With an impressive impact factor represented by its Q1 quartile rankings in both Infectious Diseases and Parasitology for 2023, this journal commands significant attention within the scientific community. Operating since 1971, it has profoundly contributed to the understanding of parasitic infections and their implications for human health, occupying a distinguished position ranked #7 out of 79 in Parasitology and #64 out of 344 in Infectious Diseases according to Scopus metrics. Although the journal currently does not offer open access options, it ensures rigorous peer review and unparalleled academic integrity, providing researchers, professionals, and students with critical insights necessary for advancing knowledge and fostering innovations in parasitology. Together with its rich historical foundation and commitment to excellence, the journal is indispensable for anyone delving into the complexities of parasites and their impact on both host and ecosystem.

Parasite Epidemiology and Control is a premier open-access journal published by Elsevier, dedicated to advancing the understanding of parasites and their impact on public health. Since its inception in 2016, the journal has established itself as a prominent publication in the fields of epidemiology, infectious diseases, and parasitology, achieving a commendable classification of Q2 in these categories as per 2023 metrics. With its ISSN 2405-6731, the journal serves as a vital resource for researchers, practitioners, and students, offering rigorous, peer-reviewed articles that illuminate parasite-related epidemiological trends and control strategies. Based in the United Kingdom, Parasite Epidemiology and Control actively promotes open access, ensuring that crucial research findings are readily accessible to a global audience, thus enhancing collaborative efforts in tackling parasitic diseases. The journal's impact is reflected in its Scopus rankings—ranking 17th in Parasitology among 79 journals, 47th in Epidemiology among 148, and 121st in Infectious Diseases among 344—underlining its significance in the scientific community. Join us in exploring this critical field and contributing to the fight against parasitic diseases through innovative research and shared knowledge.

Current Research in Parasitology & Vector-Borne Diseases, published by ELSEVIER, is an influential journal dedicated to advancing the understanding of parasitology and vector-borne diseases. With an ISSN of 2667-114X, this journal is highly esteemed in the field, holding a prestigious Q1 quartile ranking in categories such as Animal Science and Zoology, Insect Science, and Parasitology, as well as a notable Q2 ranking in Virology for 2023. The journal's focus spans a crucial intersection of disciplines, offering a platform for innovative research that directly addresses global health challenges posed by parasites and vectors. Researchers benefit from its robust open-access model, which facilitates unrestricted dissemination of knowledge, making essential findings accessible to a wider audience. The journal continues to play a pivotal role in fostering scholarly dialogue and interdisciplinary collaboration within the scientific community, serving as a vital resource for professionals, students, and academicians interested in the dynamic and evolving field of parasitology.

Parasites & Vectors is a leading open access journal dedicated to the dissemination of high-quality research on the vectors of infectious diseases and their parasitic agents. Published by BMC in the United Kingdom, this journal has been at the forefront of its field since its establishment in 2008, contributing to our understanding of vector-borne pathogens through its rigorous peer-reviewed articles. With a notable impact factor and categorized in the top quartile (Q1) in both Infectious Diseases and Parasitology, it is an essential resource for researchers, professionals, and students worldwide. The journal ranks impressively within various categories, holding a position of 7th out of 194 in Veterinary General Veterinary and 12th out of 79 in Immunology and Microbiology Parasitology, indicating its significant contribution to the sciences. Accessible to all, Parasites & Vectors supports the global pursuit of knowledge in epidemiology and disease control, making it an indispensable platform for sharing innovative findings and fostering collaboration within the scientific community.

Therapeutic Advances in Infectious Disease is a distinguished journal published by SAGE Publications Ltd, dedicated to advancing knowledge in the vital field of infectious diseases and pharmacology. With an impactful Open Access model since 2019, the journal facilitates unrestricted access to a wealth of high-quality research, enabling researchers, clinicians, and educators to stay at the forefront of infectious disease management and treatment. As a recognition of its contribution to the scientific community, the journal holds a prestigious Q1 quartile ranking in both Infectious Diseases and Medical Pharmacology as of 2023, underscoring its influence and relevance in these domains. The journal is positioned favorably within the Scopus rankings, with an impressive standing in the diverse categories of Medicine, emphasizing its commitment to disseminating innovative research. Through a rigorous peer-review process and a broad scope that covers therapeutic advancements, Therapeutic Advances in Infectious Disease serves as an essential resource for anyone involved in combating infectious diseases, offering insights that drive clinical applications and enhance patient care.

Parasite is a distinguished open-access journal published by EDP Sciences S A based in France, specializing in the multifaceted field of parasitology and related disciplines. Since its inception in 1994, it has played a pivotal role in advancing research in Agricultural and Biological Sciences, Animal Science and Zoology, Infectious Diseases, Insect Science, and Veterinary Sciences, earning a prominent place in the academic community with its 2023 rankings placing it in the Q1 category for several key areas. With an impact factor reflective of its quality and engagement, the journal fosters a collaborative environment for researchers, professionals, and students to disseminate and access high-quality studies and reviews. Operating under an open-access policy since 2013, Parasite ensures that cutting-edge research is accessible to a global audience, thereby promoting knowledge sharing and innovation in the field. For more information, please visit the journal's homepage and explore its extensive repository of articles that contribute to the understanding of parasitic interactions and their implications in health and agriculture.